The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2023

Filed:

Jun. 29, 2020
Applicant:

Biosplice Therapeutics, Inc., San Diego, CA (US);

Inventors:

Vishal Deshmukh, San Diego, CA (US);

Eric Anthony Murphy, San Marcos, CA (US);

John Hood, San Diego, CA (US);

Assignee:

BioSplice Therapeutics, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/444 (2006.01); A61P 19/04 (2006.01); A61P 17/00 (2006.01); A61K 31/5377 (2006.01); A61K 31/4439 (2006.01); A61K 31/496 (2006.01); A61K 31/501 (2006.01); A61P 17/06 (2006.01); A61K 31/4545 (2006.01); A61K 31/5355 (2006.01);
U.S. Cl.
CPC ...
A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 31/501 (2013.01); A61K 31/5355 (2013.01); A61K 31/5377 (2013.01); A61P 17/00 (2018.01); A61P 17/06 (2018.01); A61P 19/04 (2018.01);
Abstract

This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.


Find Patent Forward Citations

Deshmukh, Vishal. (2023). Methods of using indazole-3-carboxamides and their use as wnt/β-catenin signaling pathway inhibitors (U.S. Patent No. 11684615). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11684615

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…